Abstract: A method of making polyetherimide comprising reacting a first diamine having four bonds between the amine groups, a second diamine having greater than or equal to five bonds between the amine groups, 4-halophthalic anhydride and 3-halophthalic in the presence of a solvent and a polymer additive to produce a mixture comprising 3,3?-bis(halophthalimide)s, 3,4?-bis(halophthalimide)s, 4,4?-bis(halophthalimide)s, solvent and the polymer additive wherein the molar ratio of 3-halophthalic anhydride to 4-halophthalic anhydride is 98:02 to 50:50 and the molar ratio of the first diamine to the second diamine is 98:02 to 02:98; and reacting the mixture with an alkali metal salt of a dihydroxy aromatic compound to produce a polyetherimide having a cyclics content less than or equal to 5 weight percent, based on the total weight of the polyetherimide, wherein the polymer additive dissolves in the solvent at the imidization reaction temperature and pressure.

Abstract: A pluggable optical module configured to operate in a host device includes transmit optics; receive optics; an interface configured to connect to the host device, and communicatively coupled to the transmit optics and the receive optics; and circuitry communicatively coupled to the interface, wherein the circuitry is configured to, subsequent to insertion into the host device where the pluggable optical module initiates a boot process, provide an indication related to one or more of a status of the boot process and a time for the boot process to complete.

Abstract: A poly(etherimide) includes repeating units derived from polymerization of a biphenol dianhydride and an organic diamine. A method of making the poly(etherimide) includes contacting the biphenol dianhydride and the organic diamine under conditions effective to provide a poly(etherimide). The poly(etherimide) can be useful in a variety of articles, for example in an optoelectronic component.

Abstract: The invention provides a method of treating a patient having target cells that express Fc?RIIb, the method comprising administering (i) an antibody molecule that specifically binds a surface antigen of the target cell, which antibody molecule has an Fc domain capable of binding Fc?RIIb; in combination with (ii) an agent that prevents or reduces binding between the Fc domain of the antibody molecule and Fc?RIIb; characterized in that the patient is selected on the basis that their target cells express an elevated level of Fc?RIIb.

Abstract: A host device configured to receive a pluggable optical module, the host device includes circuitry configured to, subsequent to insertion of the pluggable optical module, access an early management interface on the pluggable optical module, prior to the pluggable optical module being fully booted, and, subsequent to the pluggable optical module being fully booted, access a complete management interface on the pluggable optical module. The early management interface provides responses to simple queries, allowing access to one or more registers on the pluggable optical module.

Abstract: A method (700) for verifying liveness of a finger (102) of a user by capturing a first fingerprint sample (402) from the finger (102) placed on a display (104) by using a first sensor (106) placed under the display (104). The method (700) may comprise transmitting (702) light, by using a first light transmitting display area of the display (104), towards a first area of the finger (102), wherein the first light transmitting display area (108) is smaller than a first sensor area; capturing (704) reflected light from the finger (102) by the first sensor (104), wherein the reflected light (114) is transmitted through the display (104); and identifying (706) a first feature of the first fingerprint sample (402) by using the reflected light (114), wherein the first feature comprises scattered light from the finger (102), wherein the light transmitted from the display (104) comprises a first light component with a first wavelength from a first area of the display (104).

Abstract: A polyimide composition includes 1 to 99 weight percent, preferably 70 to 99 weight percent, more preferably 75 to 95 weight percent of a first polyimide; and 1 to 99 weight percent, preferably 1 to 30 weight percent, more preferably 2 to 25 weight percent of a second polyimide, wherein the first polyimide and the second polyimide are different, and wherein the polyimide composition has a melt flow rate that is greater than a melt flow rate of the first polyimide and less than a melt flow rate of the second polyimide; an apparent viscosity that is less than an apparent viscosity of the first polyimide and less than an apparent viscosity of the second polyimide; and a notched Izod impact strength that is greater than a notched Izod impact strength of the first polyimide and greater than a notched Izod impact strength of the second polyimide.

Abstract: A radiant energy bandage assembly is disclosed. According to an exemplary embodiment, the radiant energy bandage assembly comprises an encased flexible PCBA (Printed Circuit Board Assembly) including a plurality of radiant lamps and a plurality of apertures aligned with the plurality of radiant lamps. A control pod docking interface operatively connected to the flexible PCBA provides an interface to operatively connect a user control pod to control a dosage of radiant energy to a user treatment area.

Abstract: A branched polyimide of the formula (I) wherein G is a group having a valence of t, present in an amount of 0.01 to 10 mol %, or 0.05 to 5 mol %, or 0.1 to 4 mol %, or 0.1 to 3 mol %, each of Q, M, D, V, and R are as defined herein, q is 0 or 1, m is 0 or 1, d is 0 or 1, p is 1 or 2, t is 2 to 6, preferably 2 to 4, and each n is independently the same or different, and is 1 to 1,000, provided that the total of all values of n is greater than 4, wherein the branched polyimide has a zero-shear viscosity in a range from 500 to 15,000 Pa·s, a rheology ratio of 1.1 to 5, and a strain hardening ratio of 1 to 6.

Abstract: Aspects of the present disclosure include methods for determining baseline noise of a photodetector (e.g., in a light detection system of a particle analyzer). Methods according to certain embodiments include irradiating a sample having particles in a flow stream, detecting light with the photodetector from the irradiated flow stream, generating data signals from the detected light and calculating a moving average mean squared error of the generated data signals to determine the baseline of the photodetector. Systems (e.g., particle analyzers) having a light source and a light detection system that includes a photodetector for practicing the subject methods are also described. Integrated circuits and non-transitory computer readable storage medium are also provided.

Abstract: A three step synthesis of the 8,12-dihydro-4H-dibenzo[cd,mn]pyren-3a2-ylium cation (triangulenium cation) is effected by cascade cyclization of a tetra-benzyl alcohol precursor in triflic acid solution. This cation is easily observed by NMR and optical spectroscopy. Quenching of the cation into basic solutions or by hydride transfer from triethylsilane provides access to stable dihydro and tetrahydro[3]triangulenes. This route makes several [3]triangulene precursors more readily available for development of new applications in the field of molecular electronics.

Abstract: A host device configured to receive a pluggable optical module, the host device includes circuitry configured to, subsequent to insertion of the pluggable optical module, access an early management interface on the pluggable optical module, prior to the pluggable optical module being fully booted, and, subsequent to the pluggable optical module being fully booted, access a complete management interface on the pluggable optical module. The early management interface provides responses to simple queries, allowing access to one or more registers on the pluggable optical module.

Abstract: The invention provides a method of treating a patient having target cells that express Fc?RIIb, the method comprising administering (i) an antibody molecule that specifically binds a surface antigen of the target cell, which antibody molecule has an Fc domain capable of binding Fc?RIIb; in combination with (ii) an agent that prevents or reduces binding between the Fc domain of the antibody molecule and Fc?RIIb; characterized in that the patient is selected on the basis that their target cells express an elevated level of Fc?RIIb.

Abstract: Droplet sorting modules for sorting droplets of a flow stream are described. Droplet sorting modules according to certain embodiments include a plurality of droplet sort decision units and a processor with memory operably coupled to the processor, where the memory includes instructions stored thereon, which when executed by the processor, cause the processor to determine an optimal droplet sort decision unit from the plurality of sort decision units for sorting each droplet of the flow stream. Particle (e.g., cells) sorting systems and methods for sorting droplets of a flow stream are also described. Kits having one or more of the subject droplet sorting modules are also provided.

Abstract: Security features used on identification documents such as plastic cards and passport pages are described. The security features include a textured portion that is formed on a portion of the surface of the identification document using a laser. The security features can also include a printed portion and/or a laser marked portion. The printed portion (if present) can be formed above or beneath the textured portion. The laser marked portion (if present) is formed within the thickness of the identification document below the textured portion. The textured portion and the printed portion and/or the laser marked portion can be in congruence with one another to form the security feature.

Abstract: Methods for forming and incorporating microparticles containing one or more active agents into adhesives are described. The methods involve spray drying a liquid of the one or more active agents and obtaining the active agent in a particulate form. The dry powder is then blended or otherwise incorporated with the adhesive of interest. Also described are various medical products utilizing the adhesive and one or more active agents in microparticle form, and related methods of use.

Abstract: A pluggable optical module includes one or more optical interfaces; an interface for electrically connecting to a host device; and a processor configured to, subsequent to insertion of the pluggable optical module in a host device and performance of a first stage of boot loader, execute an early management interface handler that supports access to management memory on the pluggable optical module by the host device, and continue a boot process of the pluggable optical module including loading an operating system and application software for control and management of the pluggable optical module, wherein the early management interface handler supports queries and provisioning requests from the host device while the boot process is performed. The early management interface handler is loaded after insertion, within less time than required by the full boot process.

Abstract: A system and method for mitigating security vulnerabilities of a computer network by detecting a management status of an endpoint computing device attempting to authenticate to one or more computing resources accessible via the computer network includes: detecting an authentication attempt by the endpoint computing device to the computer network; during the authentication attempt, collecting management status indicia from the endpoint computing device, wherein the management status indicia comprise data used to determine a management status of the endpoint computing device; using the management status indicia to identify the management status of the endpoint computing device and identifying the management status of the endpoint computing device; and controlling access to the computer network based on (a) whether the authentication attempt by the endpoint computing device is successful and (b) the identified management status of the endpoint computing device.

Abstract: Droplet sorting modules for sorting droplets of a flow stream are described. Droplet sorting modules according to certain embodiments include a plurality of droplet sort decision units and a processor with memory operably coupled to the processor, where the memory includes instructions stored thereon, which when executed by the processor, cause the processor to determine an optimal droplet sort decision unit from the plurality of sort decision units for sorting each droplet of the flow stream. Particle (e.g., cells) sorting systems and methods for sorting droplets of a flow stream are also described. Kits having one or more of the subject droplet sorting modules are also provided.

Abstract: Methods for forming and incorporating microparticles containing one or more active agents into adhesives are described. The methods involve spray drying a liquid of the one or more active agents and obtaining the active agent in a particulate form. The dry powder is then blended or otherwise incorporated with the adhesive of interest. Also described are various medical products utilizing the adhesive and one or more active agents in microparticle form, and related methods of use.